Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML.

Banegas MP, Rivera DR, O'Keeffe-Rosetti MC, Carroll NM, Pawloski PA, Tabano DC, Epstein MM, Yeung K, Hornbrook MC, Lu C, Ritzwoller DP.

J Natl Compr Canc Netw. 2019 Oct 1;17(10):1166-1172. doi: 10.6004/jnccn.2019.7303.

PMID:
31590146
2.

Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network.

Burnett-Hartman AN, Udaltsova N, Kushi LH, Neslund-Dudas C, Rahm AK, Pawloski PA, Corley DA, Knerr S, Feigelson HS, Hunter JE, Tabano DC, Epstein MM, Honda SA, Ter-Minassian M, Lynch JA, Lu CY.

JCO Clin Cancer Inform. 2019 Sep;3:1-10. doi: 10.1200/CCI.19.00026.

3.

Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus.

Kent DJ, McMahill-Walraven CN, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM.

J Manag Care Spec Pharm. 2019 Nov;25(11):1162-1171. doi: 10.18553/jmcp.2019.19042. Epub 2019 Aug 12.

4.

Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to Evaluate Patterns of Care.

McMahill-Walraven CN, Kent DJ, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM.

J Manag Care Spec Pharm. 2019 Nov;25(11):1156-1161. doi: 10.18553/jmcp.2019.19041. Epub 2019 Aug 9.

5.

Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network.

Burnett-Hartman AN, Powers JD, Chubak J, Corley DA, Ghai NR, McMullen CK, Pawloski PA, Sterrett AT, Feigelson HS.

Cancer Causes Control. 2019 Jul;30(7):747-755. doi: 10.1007/s10552-019-01181-3. Epub 2019 May 17.

PMID:
31102084
6.

PCSK9 Inhibitor Use in the Real World: Data From the National Patient-Centered Research Network.

Chamberlain AM, Gong Y, Shaw KM, Bian J, Song WL, Linton MF, Fonseca V, Price-Haywood E, Guhl E, King JB, Shah RU, Puro J, Shenkman E, Pawloski PA, Margolis KL, Hernandez AF, Cooper-DeHoff RM.

J Am Heart Assoc. 2019 May 7;8(9):e011246. doi: 10.1161/JAHA.118.011246.

7.

The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine.

Rahm AK, Ladd I, Burnett-Hartman AN, Epstein MM, Lowery JT, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Hunter JE.

EGEMS (Wash DC). 2019 Apr 12;7(1):16. doi: 10.5334/egems.283.

8.

Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients.

Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):996-999. doi: 10.1158/1055-9965.EPI-18-1324. Epub 2019 Apr 9.

PMID:
30967418
9.

A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice.

Pawloski PA, Brooks GA, Nielsen ME, Olson-Bullis BA.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):331-338. doi: 10.6004/jnccn.2018.7104.

10.

Health-related quality of life among US adults with cancer: Potential roles of complementary and alternative medicine for health promotion and well-being.

Rhee TG, Pawloski PA, Parsons HM.

Psychooncology. 2019 Apr;28(4):896-902. doi: 10.1002/pon.5039. Epub 2019 Mar 13.

PMID:
30803097
11.

Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.

Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, Nyboer RA, Pawloski PA, Maciosek MV, Trower NK, O'Connor PJ.

JAMA Netw Open. 2018 Sep 7;1(5):e181617. doi: 10.1001/jamanetworkopen.2018.1617.

12.

Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.

Rahm AK, Cragun D, Hunter JE, Epstein MM, Lowery J, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Burnett-Hartman AN, Gudgeon JM, Hao J, Snyder S, Gogoi R, Ladd I, Williams MS.

BMC Health Serv Res. 2018 Oct 30;18(1):824. doi: 10.1186/s12913-018-3636-2.

13.

Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings.

Raman SR, Brown JS, Curtis LH, Haynes K, Marshall J, Pawloski PA, Platt R.

J Gen Intern Med. 2019 Mar;34(3):341-343. doi: 10.1007/s11606-018-4697-y. No abstract available.

PMID:
30350029
14.

Economic Evaluation of the Home Blood Pressure Telemonitoring and Pharmacist Case Management to Control Hypertension (Hyperlink) Trial.

Dehmer SP, Maciosek MV, Trower NK, Asche SE, Bergdall AR, Nyboer RA, O'Connor PJ, Pawloski PA, Sperl-Hillen JM, Green BB, Margolis KL.

J Am Coll Clin Pharm. 2018 Oct;1(1):21-30. doi: 10.1002/jac5.1001. Epub 2018 Apr 14.

15.

Pregnancy-Associated Cancer: A U.S. Population-Based Study.

Cottreau CM, Dashevsky I, Andrade SE, Li DK, Nekhlyudov L, Raebel MA, Ritzwoller DP, Partridge AH, Pawloski PA, Toh S.

J Womens Health (Larchmt). 2019 Feb;28(2):250-257. doi: 10.1089/jwh.2018.6962. Epub 2018 Oct 10.

PMID:
30307780
16.

Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists.

Beran M, Asche SE, Bergdall AR, Crabtree B, Green BB, Groen SE, Klotzle KJ, Michels RD, Nyboer RA, O'Connor PJ, Pawloski PA, Rehrauer DJ, Sperl-Hillen JM, Trower NK, Margolis KL.

J Am Pharm Assoc (2003). 2018 Nov - Dec;58(6):614-621. doi: 10.1016/j.japh.2018.07.001. Epub 2018 Aug 1.

17.

Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey.

McMullen C, Bulkley J, Corley DA, Madrid S, Davis AQ, Hesselbrock R, Kurtilla F, Anderson CK, Arterburn D, Somkin CP, Pawloski PA, Ghai NR, Feigelson HS.

Support Care Cancer. 2019 Jan;27(1):147-156. doi: 10.1007/s00520-018-4299-6. Epub 2018 Jun 12.

18.

Opioid Use During Pregnancy, Observations of Opioid Use, and Secular Trend From 2006 to 2014 at HealthPartners Medical Group.

Elliott TE, Frail CK, Pawloski PA, Thomas AJ, Werner AM, Rossom RC.

Clin J Pain. 2018 Aug;34(8):707-712. doi: 10.1097/AJP.0000000000000592.

PMID:
29406367
19.

Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors.

Feigelson HS, McMullen CK, Madrid S, Sterrett AT, Powers JD, Blum-Barnett E, Pawloski PA, Ziegenfuss JY, Quinn VP, Arterburn DE, Corley DA.

J Cancer Surviv. 2017 Jun;11(3):393-400. doi: 10.1007/s11764-017-0596-1. Epub 2017 Jan 13.

20.

Establishment of Personalized Pain Goals in Oncology Patients to Improve Care and Decrease Costs.

Zylla D, Larson A, Chuy G, Illig L, Peck A, Van Peursem S, Fulbright JW, Pawloski PA, Richter S, Mettner J.

J Oncol Pract. 2017 Mar;13(3):e266-e272. doi: 10.1200/JOP.2016.017616. Epub 2017 Jan 3.

PMID:
28045611
21.

Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management.

Asche SE, O'Connor PJ, Dehmer SP, Green BB, Bergdall AR, Maciosek MV, Nyboer RA, Pawloski PA, Sperl-Hillen JM, Trower NK, Margolis KL.

J Am Soc Hypertens. 2016 Nov;10(11):873-880. doi: 10.1016/j.jash.2016.09.004. Epub 2016 Sep 25.

22.

The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.

Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH.

Cancer Causes Control. 2016 Nov;27(11):1315-1323. Epub 2016 Sep 17.

23.

Predicting neutropenia risk in patients with cancer using electronic data.

Pawloski PA, Thomas AJ, Kane S, Vazquez-Benitez G, Shapiro GR, Lyman GH.

J Am Med Inform Assoc. 2017 Apr 1;24(e1):e129-e135. doi: 10.1093/jamia/ocw131.

24.

Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.

Fortuna LA, Pawloski PA, Parker ED, Trower NK, Kottke TE.

Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):13-9. doi: 10.1093/ehjcvp/pvv036. Epub 2015 Sep 7.

PMID:
27533057
25.

A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management.

Pawloski PA, Asche SE, Trower NK, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, O'Connor PJ, Sperl-Hillen JM, Green BB, Margolis KL.

J Clin Pharm Ther. 2016 Oct;41(5):493-8. doi: 10.1111/jcpt.12414. Epub 2016 Jun 30.

26.

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.

Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R.

Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):170-8. doi: 10.1002/pds.3919. Epub 2015 Nov 24.

27.

Training in the Conduct of Population-Based Multi-Site and Multi-Disciplinary Studies: the Cancer Research Network's Scholars Program.

Buist DSM, Field TS, Banegas MP, Clancy HA, Doria-Rose VP, Epstein MM, Greenlee RT, McDonald S, Nichols HB, Pawloski PA, Kushi LH.

J Cancer Educ. 2017 Jun;32(2):283-292. doi: 10.1007/s13187-015-0925-x.

28.

Pegfilgrastim use and bone pain: a cohort study of community-based cancer patients.

Pawloski PA, Larsen M, Thoresen A, Giordana MD.

J Oncol Pharm Pract. 2016 Jun;22(3):423-9. doi: 10.1177/1078155215585188. Epub 2015 May 7.

PMID:
25956422
29.

A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?

Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, O'Connor PJ, Pawloski PA, Sperl-Hillen JM, Trower NK, Tucker AD, Green BB.

J Gen Intern Med. 2015 Nov;30(11):1665-72. doi: 10.1007/s11606-015-3355-x.

30.

Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.

Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP.

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):684-92. doi: 10.1002/pds.3778. Epub 2015 Apr 24.

PMID:
25914229
31.

Trends in elective labor induction for six United States health plans, 2001-2007.

Dublin S, Johnson KE, Walker RL, Avalos LA, Andrade SE, Beaton SJ, Davis RL, Herrinton LJ, Pawloski PA, Raebel MA, Smith DH, Toh S, Caughey AB.

J Womens Health (Larchmt). 2014 Nov;23(11):904-11. doi: 10.1089/jwh.2014.4779. Epub 2014 Oct 20.

32.

Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.

Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM.

Breast Cancer Res Treat. 2014 Jul;146(2):401-9. doi: 10.1007/s10549-014-3021-8. Epub 2014 Jun 18.

33.

Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample.

Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KA; CERGEN Study Team.

PLoS One. 2014 May 1;9(5):e94977. doi: 10.1371/journal.pone.0094977. eCollection 2014.

34.

Chronic opioid use emerging after bariatric surgery.

Raebel MA, Newcomer SR, Bayliss EA, Boudreau D, DeBar L, Elliott TE, Ahmed AT, Pawloski PA, Fisher D, Toh S, Donahoo WT.

Pharmacoepidemiol Drug Saf. 2014 Dec;23(12):1247-57. doi: 10.1002/pds.3625. Epub 2014 Apr 14.

PMID:
24733580
35.

Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer.

Lash TL, Thwin SS, Yood MU, Geiger AM, Bosco J, Quinn VP, Field TS, Pawloski PA, Silliman RA.

Breast Cancer Res Treat. 2014 Apr;144(3):643-63. doi: 10.1007/s10549-014-2885-y. Epub 2014 Mar 1.

36.

Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic.

Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R.

Pharmaceutics. 2013 Mar 14;5(1):179-200. doi: 10.3390/pharmaceutics5010179.

37.

Chronic use of opioid medications before and after bariatric surgery.

Raebel MA, Newcomer SR, Reifler LM, Boudreau D, Elliott TE, DeBar L, Ahmed A, Pawloski PA, Fisher D, Donahoo WT, Bayliss EA.

JAMA. 2013 Oct 2;310(13):1369-76. doi: 10.1001/jama.2013.278344.

PMID:
24084922
38.

Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel.

Walsh KE, Cutrona SL, Foy S, Baker MA, Forrow S, Shoaibi A, Pawloski PA, Conroy M, Fine AM, Nigrovic LE, Selvam N, Selvan MS, Cooper WO, Andrade S.

Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1205-13. doi: 10.1002/pds.3505. Epub 2013 Sep 5.

39.

Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database.

Lo Re V 3rd, Haynes K, Goldberg D, Forde KA, Carbonari DM, Leidl KB, Hennessy S, Reddy KR, Pawloski PA, Daniel GW, Cheetham TC, Iyer A, Coughlin KO, Toh S, Boudreau DM, Selvam N, Cooper WO, Selvan MS, VanWormer JJ, Avigan MI, Houstoun M, Zornberg GL, Racoosin JA, Shoaibi A.

Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):861-72. doi: 10.1002/pds.3470. Epub 2013 Jun 25.

40.

Fracture risk in older, long-term survivors of early-stage breast cancer.

Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JL, Thwin SS, Silliman RA, Field TS.

J Am Geriatr Soc. 2013 Jun;61(6):888-95. doi: 10.1111/jgs.12269. Epub 2013 May 6.

41.

Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.

Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA; CERGEN study team.

Genet Med. 2013 Dec;15(12):933-40. doi: 10.1038/gim.2013.43. Epub 2013 May 2.

42.

Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes.

Johnson KE, Beaton SJ, Andrade SE, Cheetham TC, Scott PE, Hammad TA, Dashevsky I, Cooper WO, Davis RL, Pawloski PA, Raebel MA, Smith DH, Toh S, Li DK, Haffenreffer K, Dublin S.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):776-82. doi: 10.1002/pds.3443. Epub 2013 Apr 18.

43.

Patient characteristics associated with medication adherence.

Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ.

Clin Med Res. 2013 Jun;11(2):54-65. doi: 10.3121/cmr.2013.1113. Epub 2013 Apr 11.

44.

Drug safety data mining with a tree-based scan statistic.

Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, Platt R, Andrade SE, Boudreau D, Gunter MJ, Herrinton LJ, Pawloski PA, Raebel MA, Roblin D, Brown JS.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):517-23. doi: 10.1002/pds.3423. Epub 2013 Mar 20.

PMID:
23512870
45.

The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007.

Avalos LA, Chen H, Yang C, Andrade SE, Cooper WO, Cheetham CT, Davis RL, Dublin S, Hammad TA, Kaplan S, Pawloski PA, Raebel MA, Scott PE, Smith DH, Toh S, Li DK.

Matern Child Health J. 2014 Jan;18(1):64-72. doi: 10.1007/s10995-013-1234-9.

46.

Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE.

Arch Womens Ment Health. 2013 Apr;16(2):149-57. doi: 10.1007/s00737-013-0330-6. Epub 2013 Feb 7.

47.

Validation of an algorithm to estimate gestational age in electronic health plan databases.

Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Dashevsky I, Haffenreffer K, Johnson KE, Toh S.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):524-32. doi: 10.1002/pds.3407. Epub 2013 Jan 21.

48.

Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up.

Clough-Gorr KM, Thwin SS, Bosco JL, Silliman RA, Buist DS, Pawloski PA, Quinn VP, Prout MN.

Cancer. 2013 Apr 15;119(8):1478-85. doi: 10.1002/cncr.27914. Epub 2012 Dec 26.

49.

Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.

Lawrence JM, Andrade SE, Avalos LA, Beaton SJ, Chiu VY, Davis RL, Dublin S, Pawloski PA, Raebel MA, Smith DH, Toh S, Wang JQ, Kaplan S, Amini T, Hampp C, Hammad TA, Scott PE, Cheetham TC; Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Study Group.

Obstet Gynecol. 2013 Jan;121(1):106-14. doi: http://10.1097/AOG.0b013e318278ce86.

50.

KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.

Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA; CERGEN study team.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):91-101. doi: 10.1158/1055-9965.EPI-12-0545. Epub 2012 Nov 15.

Supplemental Content

Loading ...
Support Center